The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 480.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.167%)
Open: 490.00
High: 490.00
Low: 490.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2023 07:00

RNS Number : 8896V
System1 Group PLC
12 April 2023
 

 

 

12 April 2023

 

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Final Quarter Trading Update

 

 

System1 today issues an update on trading for the quarter ended 31 March 2023 (Q4).

 

 

FY23

Revenue £ million - unaudited *

Q1

Q2

H1

Q3

Q4

H2

FY

Jun-22

Sep-22

Dec-22

Mar-23

Mar-23

Predict Your (data)

2,964

3,189

6,153

3,400

4,107

7,507

13,660

Improve Your (data-led consultancy)

752

694

1,446

862

1,163

2,025

3,471

Standard (platform revenue)

3,716

3,883

7,599

4,262

5,270

9,532

17,131

Other consultancy (non-platform)

1,529

1,368

2,897

1,964

1,354

3,318

6,215

Total Revenue

5,245

5,251

10,496

6,226

6,624

12,850

23,346

 

 * The Company has disclosed additional information in relation to the breakdown of revenues, which it intends to provide going forward. All numbers in this announcement are unaudited and therefore may be subject to change.

 

During Q4, the Company made substantial and measurable progress towards the strategic objectives that the board set out following the strategic review, specifically growing our standard Predict Your and Improve Your products (platform-based data and consultancy) to a point where they represented 80% of revenue in Q4.

Predict Your (data) revenue grew by 67% on the comparable prior-year quarter to £4.1m, a quarterly record, and by 40% for the financial year to £13.7m. Improve Your (data-led consultancy) revenue increased by 95% over the comparable prior-year quarter and by 29% for the financial year overall. Standard product revenues therefore grew by 73% on Q4 FY22 and by 38% for the financial year and represented 80% of revenues in Q4 and 73% for the financial year.

For the year as a whole, Other Consultancy (non-platform) revenue was £5.5m lower at £6.2m. In H2 Other Consultancy revenue grew on H1, following three successive periods of half-on-half reduction, reinforcing the Board's belief that the decline in non-strategic revenue is substantially behind us.

Total Group revenue rose by 26% in Q4 and 9% in H2 ending the year at £23.3m, 3% lower than FY22 (standard platform revenue +38%, Other non-platform consultancy -47%).

Excellent progress was made in the US in Q4 where we won new mandates from 3 of the country's 25 biggest advertising spenders, including the largest. The US delivered its highest half year of revenue since FY21, and standard product revenue increased by 23% for the year as a whole.

 

Following the launch of Test Your Idea, Innovation product revenue increased by 28% in H2 versus H1. Communications products, primarily Test Your Ad, continued to grow by over 20% H2 on H1. Brand grew by 12% year on year, helped by the first full year of Test Your Brand.

 

The improved revenue performance in H2 is expected to bring a return to profitability at adjusted and statutory levels for H2 and also for the year as a whole, based on the unaudited management accounts, and the Board now anticipates that profit for the year ended 31 March 2023 will slightly exceed its previous expectations. As indicated in the 23 February 2023 trading update, there was a cash inflow during Q4, resulting in year-end net cash of £5.7m.

 

Commenting on the results, CEO James Gregory said: "I am delighted with the upturn in performance in the second half-year. The profitable growth in our standard, platform-based products in the US and elsewhere demonstrates that we have the right strategy, business model and management team."

 

General Meeting 21 April

The company has called a general meeting for 21 April 2023 to consider four resolutions proposed by shareholders Stefan Barden and James Geddes ("Requisitioning Shareholders"). The Board believes that the latest quarter's trading performance demonstrates that the company's product and go-to-market strategy is correct, and that management is executing the plan effectively. We repeat our recommendation in the Circular dated 24 March 2023 that the Board considers that all the resolutions proposed by the Requisitioning Shareholders are not in the best interest of the Company and the shareholders as a whole, and that the Board will be voting against all of them and unanimously recommends that shareholders do the same.

 

Further information on the Company can be found at www.system1group.com.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited (Nominated Adviser & Broker)

Tel: +44 (0)20 7523 8000

 

Simon Bridges / Andrew Potts

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBQCBKDKQD
Date   Source Headline
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.